ELOXX PHARMACEUT(ELOX) - 2023 Q2 - Quarterly Report

Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Commission File Number: 001-31326 ELOXX PHARMACEUTICALS, INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition pe ...